Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis
Open Access
- 18 October 2023
- journal article
- review article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 25 (12) , 1053-1068
Abstract
Hypertension is a major public health issue worldwide. The imbalance of gut microbiota is thought to play an important role in the pathogenesis of hypertension. The authors conducted the systematic review and meta‐analysis to clarify the relationship between gut microbiota and hypertension through conducting an electronic search in six databases. Our meta‐analysis included 19 studies and the results showed that compared with healthy controls, Shannon significantly decreased in hypertension [SMD = −0.13, 95%CI (−0.22, −0.04), p = .007]; however, Simpson [SMD = −0.01, 95%CI (−0.14, 0.12), p = .87], ACE [SMD = 0.18, 95%CI (−0.06, 0.43), p = .14], and Chao1 [SMD = 0.11, 95%CI (−0.01, 0.23), p = .08] did not differ significantly between hypertension and healthy controls. The F/B ratio significantly increased in hypertension [SMD = 0.84, 95%CI (0.10, 1.58), p = .03]. In addition, Shannon index was negatively correlated with hypertension [r = −0.12, 95%CI (−0.19, −0.05)], but had no significant correlation with SBP [r = 0.10, 95%CI (−0.19, 0.37)] and DBP [r = −0.39, 95%CI (−0.73, 0.12)]. At the phylum level, the relative abundance of Firmicutes [SMD = −0.01, 95%CI (−0.37, 0.34), p = .94], Bacteroidetes [SMD = −0.15, 95%CI (−0.44, 0.14), p = .30], Proteobacteria [SMD = 0.25, 95%CI (−0.01, 0.51), p = .06], and Actinobacteria [SMD = 0.21, 95%CI (−0.11, 0.53), p = .21] did not differ significantly between hypertension and healthy controls. At the genus level, compared with healthy controls, the relative abundance of Faecalibacterium decreased significantly [SMD = −0.16, 95%CI (−0.28, −0.04), p = .01], while the Streptococcus [SMD = 0.20, 95%CI (0.08, 0.32), p = .001] and Enterococcus [SMD = 0.20, 95%CI (0.08, 0.33), p = .002] significantly increased in hypertension. Available evidence suggests that hypertensive patients may have an imbalance of gut microbiota. However, it still needs further validation by large sample size studies of high quality.Keywords
This publication has 59 references indexed in Scilit:
- Association of night-time home blood pressure with night-time ambulatory blood pressure and target-organ damageJournal Of Hypertension, 2017
- Alterations in the gut microbiota can elicit hypertension in ratsPhysiological Genomics, 2017
- Global Disparities of Hypertension Prevalence and ControlCirculation, 2016
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and ExplanationsAnnals of Internal Medicine, 2015
- Gut Dysbiosis Is Linked to HypertensionHypertension, 2015
- Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFκB activationNutrition, Metabolism and Cardiovascular Diseases, 2014
- The Virome in Mammalian Physiology and DiseaseCell, 2014
- The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibitionProceedings of the National Academy of Sciences of the United States of America, 2014
- HDAC Inhibition Attenuates Inflammatory, Hypertrophic, and Hypertensive Responses in Spontaneously Hypertensive RatsHypertension, 2010
- On the Use of Beta Coefficients in Meta-Analysis.Journal of Applied Psychology, 2005